Escalon Medical Corp.
Escalon Medical Corp.
Your view on ESMC
Overview
What the company does, where it operates, and who runs it.
About Escalon Medical Corp.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Richard J. DePiano Jr.
- Headquarters
- 435 Devon Park Drive, Wayne, PA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Richard J. DePiano Jr.
- Headquarters
- 435 Devon Park Drive, Wayne, PA, US
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally.
It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.
The company also distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient.
In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location.
The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Escalon Medical Corp., and the rating behind it. ESMC last traded at $0.25, 1.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Escalon Medical Corp.. Starting points for Escalon Medical Corp.: P/E 1.5, EPS $0.25, beta 0.29 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Escalon Medical Corp.. Escalon Medical Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Escalon Medical Corp.. Trailing twelve-month EPS for Escalon Medical Corp. stands at $0.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Escalon Medical Corp.. Escalon Medical Corp. has reported as a listed company since 1992. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Escalon Medical Corp. valued side by side against its closest peers. Escalon Medical Corp. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Escalon Medical Corp., and how their positions are changing. At a $1.9M market value, institutional positions materially move Escalon Medical Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Escalon Medical Corp. executives and directors. Shares of Escalon Medical Corp. have traded between $0.10 and $0.46 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Escalon Medical Corp.. Escalon Medical Corp. is a $1.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Escalon Medical Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Escalon Medical Corp.. Coverage tracks Escalon Medical Corp. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.